Health
No benefit from virus blood plasma: study – The West Australian
A trial looking at whether blood plasma from COVID-19 patients can help those who are seriously ill does not appear to work in ICU patients, researchers say.
An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators say.
The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product – an antibody-rich plasma taken from people who have recovered from the pandemic…
-
General20 hours agoTony Burke’s detention inaction | The Spectator Australia
-
General19 hours agoGrattan Institute pitches blueprint to ‘save’ NDIS as foundational supports rollout stalls
-
General23 hours agoTasmania’s business lobby backing Labor’s budget savings measures, as Liberals launch state election campaign
-
General23 hours agoIf Iran’s regime fell tomorrow, Iranians wouldn’t be united on what comes next